Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Synlogic, Inc. (NASDAQ: SYBX).

Full DD Report for SYBX

You must become a subscriber to view this report.


Recent News from (NASDAQ: SYBX)

3 Young Biotechs Positioned To Upend Medicine
Introduction The following three stocks are biotechnology companies that could upend medicine as we know it. The therapeutics they are developing are novel and could be revolutionary. While we recommend buying shares in these stocks, at the prices listed, for a long-term hold, they may not p...
Source: SeekingAlpha
Date: May, 17 2018 10:51
Lucky Seven: Immune Design Takes Off, Institutions Place Bets On Viking Therapeutics
Lucky Seven The Lucky Seven is a swing-trading biotechnology portfolio of seven stocks listed in a way to reflect top picks and risk tolerance. The first three picks are the top picks (in no particular order). Risks are increased the further away a stock sits from #4 (the least risky stoc...
Source: SeekingAlpha
Date: May, 16 2018 03:55
Synlogic beats by $0.18, beats on revenue
Synlogic (NASDAQ: SYBX ): Q1 EPS of -$0.55 beats by $0.18 . More news on: Synlogic, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 15 2018 07:09
Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update
– Treated first subject in clinical trials of two Synthetic Biotic TM medicines, SYNB1020 and SYNB1618; both studies expected to generate data in 2018 – Synlogic, Inc. ( Nasdaq: SYBX ), a clinical stage company applying synthetic biology to probiotics to develop nov...
Source: Business Wire
Date: May, 15 2018 07:00
Lucky Seven: Achaogen Likely To Bounce Back
The biotechnology sector ( XBI ) felt good about itself last week. As a result, many of the promising, up-and-coming biotechnology companies saw investors throwing their cash back at them in hopes of profitable returns. We anticipate the trend will continue, at least for a short time: C...
Source: SeekingAlpha
Date: May, 14 2018 08:19
Synlogic Announces Leadership Change
– Jose Carlos Gutiérrez-Ramos resigns as Synlogic’s President and Chief Executive Officer and member of its board of directors – – Aoife Brennan, current Synlogic Chief Medical Officer, named Interim President and Chief Executive Officer – ...
Source: Business Wire
Date: May, 10 2018 16:10
Lucky Seven: Omeros Moves, Array Biopharma May Be Next
iShares Nasdaq Biotechnology ETF ( IBB ) was good for a 0.3% gain within the last three trading days, while the Lucky Seven netted a 2.6% gain. The Lucky Seven portfolio assumes an investor made a $1000 investment, to begin, in each pick. So, the portfolio began with $7,000. Lucky Seven ...
Source: SeekingAlpha
Date: May, 08 2018 15:02
Institutional Top Ideas Series: Orbimed Advisors
In the last entry of this series, we took a look at top ideas from Baker Bros. Advisors (whose performance has been struggling of late but they've built up a stellar reputation and track record of long term outperformance). Going forward, I hope to continue to delve into the portfolios of...
Source: SeekingAlpha
Date: May, 04 2018 03:18
Lucky Seven: An Introduction To My Top Biotechnology Picks
Introduction I am a Registered Nurse, currently advancing my education at Purdue University. I work on an intermediate care unit in a hospital where I am responsible for the care and lives of folks who come to me with a myriad of medical conditions. I hope to soon become a nursing professor....
Source: SeekingAlpha
Date: May, 03 2018 05:28
Synlogic Receives Fast-Track Designation for SYNB1618, a Synthetic Biotic(TM) medicine for the Treatment of Phenylketonuria
– Phase 1/2a clinical study of SYNB1618 evaluating safety and tolerability as well as exploratory endpoints expected to report interim data in 2018 – Synlogic ( Nasdaq: SYBX ), a clinical-stage company applying synthetic biology to probiotic bacteria to develop novel liv...
Source: Business Wire
Date: April, 25 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1710.209.9710.399.6795,504

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1715,44921,15273.0380Short
2018-08-1612,054127,2269.4745Cover
2018-08-1512,22122,21255.0198Short
2018-08-1432,51259,16854.9486Short
2018-08-1320,99343,13248.6715Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SYBX.


About Synlogic, Inc. (NASDAQ: SYBX)

Logo for Synlogic, Inc. (NASDAQ: SYBX)

Not available

 

Contact Information

 

 

Current Share Structure

     


    Recent Filings from (NASDAQ: SYBX)

    Quarterly report with a continuing view of a company's financial position
    Filing Type: 10-QFiling Source: edgar
    Filing Date: May, 15 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: May, 15 2018
    Additional proxy soliciting materials - definitive
    Filing Type: DEFA14AFiling Source: edgar
    Filing Date: May, 15 2018
    Statement of beneficial ownership of common stock by certain persons
    Filing Type: SC 13GFiling Source: edgar
    Filing Date: May, 10 2018
    Official notification to shareholders of matters to be brought to a vote (Proxy)
    Filing Type: DEF 14AFiling Source: edgar
    Filing Date: April, 27 2018
    Statement of beneficial ownership of common stock by certain persons
    Filing Type: SC 13GFiling Source: edgar
    Filing Date: April, 16 2018
    Amendment to a SC 13D filing
    Filing Type: SC 13D/AFiling Source: edgar
    Filing Date: April, 12 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: April, 06 2018
    Prospectus filed under Rule 424(b)(5)
    Filing Type: 424B5Filing Source: edgar
    Filing Date: April, 06 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: March, 20 2018

     

     


    Daily Technical Chart for (NASDAQ: SYBX)

    Daily Technical Chart for (NASDAQ: SYBX)


    Stay tuned for daily updates and more on (NASDAQ: SYBX)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: SYBX)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SYBX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of SYBX and does not buy, sell, or trade any shares of SYBX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/